| 1 | Furey et al. 2025. Subjective vs objective cognition in menopause. J Int Neuropsychol Soc. doi:10.1017/S1355617725101306 | Pooled analysis, 24 comparisons | Moderate (studies varied a lot) |
| 2 | Maki PM, Jaff NG. 2022. Brain fog in menopause: a health-care professional's guide. Climacteric. doi:10.1080/13697137.2022.2122792 | Expert review | Moderate |
| 3 | Greendale GA et al. 2009. Effects of the menopause transition and hormone use on cognitive performance. Neurology. doi:10.1212/WNL.0b013e3181a71193 | Large US cohort (size to add from card) | Moderate |
| 4 | Bromberger JT et al. 2013. Does risk for anxiety increase during the menopausal transition? SWAN. Menopause. doi:10.1097/GME.0b013e3182730599 | Large US cohort, 2,956 women | Moderate |
| 5 | Badawy Y et al. 2024. Depression risk in the menopausal transition. J Affect Disord 357:126-133. doi:10.1016/j.jad.2024.04.041 | Pooled analysis, 7 studies, 9,141 women | Strong |
| 6 | Brent SE, Shirreff L, Yanchar NL, Christakis M. 2025. Workplace impact of menopause symptoms among Canadian women physicians. Healthcare 13(21):2699. doi:10.3390/healthcare13212699 | Survey, 217 women (volunteers) | Limited |
| 7 | Menopause Foundation of Canada. 2022. Menopause and Work in Canada (Leger online survey). Sponsored by Sun Life; not peer reviewed | Survey, 1,023 women | Moderate |
| 8 | Taylor S, Callahan B, Grant J, Islam RM, Davis SR. 2025. Menopause and work performance: a systematic review of observational studies. Menopause. doi:10.1097/GME.0000000000002557 | Systematic review, 10 studies | Limited |
| 9 | Brotto LA et al. 2026. Maturitas 207:108874. doi:10.1016/j.maturitas.2026.108874 | Survey, 1,850 women (volunteers) | Moderate |
| 10 | Ballantyne EC, King JP, Green SM. 2021. Cognitive remediation pilot for women in the menopausal transition. Front Glob Womens Health 2:741539. doi:10.3389/fgwh.2021.741539 | Pilot, 27 women, no comparison group | Limited |
| 11 | VA/DoD Clinical Practice Guideline for the Management of Menopause. 2026 | Guideline | Cross-check; primary trials still to find for exercise, hormone therapy and plant estrogens |
| 12 | Bachkangi et al. 2026. Menopause Rev 25(1):36-44. doi:10.5114/pm.2026.162164 | Review | Moderate |
| 13 | Maki PM et al. 2018. Guidelines on menopause and mental health (full citation to copy from card MOOD-002) | Guideline | Moderate |
| 14 | Xu C, Bi S, Zhang W, Luo L. 2024. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Front Nutr 11:1424972. doi:10.3389/fnut.2024.1424972 (a 2025 correction exists and has not been checked) | Pooled analysis, 16 trials, 492 adults | Moderate for memory; low certainty for speed and attention |
| 15 | Korovljeva D et al. 2025. Creatine HCl and creatine ethyl ester in perimenopausal and menopausal women (CONCRET-MENOPA). J Am Nutr Assoc (full citation to confirm; read through a news summary only) | Placebo-controlled trial, 36 women | Limited |
| 16 | McCurry SM, Sternfeld B, LaCroix AZ, et al. 2016. Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: a MsFLASH randomized clinical trial. JAMA Intern Med 176(7):913-920 (DOI to add) | Randomized trial, 106 women, active comparison | Moderate |
| 17 | Carmody JF, Crawford S, Salmoirago-Blotcher E, Leung K, Churchill L, Olendzki N. 2011. Mindfulness training for coping with hot flashes: results of a randomized trial. Menopause. doi:10.1097/gme.0b013e318204a05c | Randomized trial, 110 women, wait-list comparison | Limited |
| 18 | Marshall S, Kitzan A, Wright J, Bocicariu L, Nagamatsu LS. 2026. Creatine and cognition in aging: a systematic review of evidence in older adults. Nutr Rev 84(2):333-344. doi:10.1093/nutrit/nuaf135 | Systematic review, 6 studies, 1,542 adults aged 55+ | Limited |